Advances in Neoadjuvant Targeted Therapy for Non-small Cell Lung Can-cer
With the benefit of targeted therapy for patients with advanced non-small cell lung cancer(NSCLC)with positive driver genes and postoperative adjuvant therapy,neoadjuvant strategies of targeted therapy for lung cancer are increasingly attracting attention.In recent years,the data of clinical trials of neoadjuvant targeted therapy in NSCLC have been constantly updated.Neoadjuvant targeted therapy in NSCLC is safe and effective,which can increase the chance of radical surgery,reduce disease recurrence and improve patient prognosis.This article reviews the relevant studies on the application of neoadjuvant targeted therapy in driver gene-positive NSCLC,in order to improve clini-cians'understanding of neoadjuvant targeted therapy.
NETL
NSTL
万方数据
维普
